Stimulated autologous CD4+ T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Stimulated autologous CD4+ T cells, covering 2017-08-22 to 2017-08-22. Get the full timeline:
Most recent: Clinical Trial Update: A Trial for Evaluating Both Safety and Preliminary Efficacy of a Single Infusion of Stimulated Autologous CD4+T Cells in Patients With Relapsing- Remitting Multiple Sclerosis [Phase 1, Phase 2]